Sonedenoson

Description: Sonedenoson (MRE0094) is an adenosine A(2A) receptor agonist and potential inhibitor potentially targeting SARS-CoV-2 coronavirus 2,-O-ribose methyltransferase, and may be used in the study of diabetic foot ulcers. Target: Adenosine Receptor, SARS-CoV. Smiles: O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=C(OCCC4=CC=C(Cl)C=C4)N3)O[C@H](CO)[C@H]1O. References: Boncler M, et al. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y12 antagonists. Vascul Pharmacol. 2019 Feb,113:47-56.